atazanavir sulfate has been researched along with buprenorphine in 4 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (buprenorphine) | Trials (buprenorphine) | Recent Studies (post-2010) (buprenorphine) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 7,273 | 1,223 | 3,826 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altice, FL; Bruce, RD | 1 |
DiFrancesco, R; Donnelly, J; Fischl, MA; Gripshover, B; McCance-Katz, EF; Moody, DE; Morse, GD; Reichman, RC; Zingman, BS | 1 |
DiFrancesco, R; Friedland, G; Ma, Q; McCance-Katz, EF; Moody, DE; Morse, GD; Pade, P; Rainey, PM | 1 |
Altice, F; Botsko, M; Egan, JE; Fiellin, DA; Nandi, V; O'Connor, PG; Sullivan, LE; Tozzi, MJ; Vergara-Rodriguez, P | 1 |
4 other study(ies) available for atazanavir sulfate and buprenorphine
Article | Year |
---|---|
Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir.
Topics: Atazanavir Sulfate; Buprenorphine; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Narcotics; Oligopeptides; Pyridines; Ritonavir | 2006 |
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Biological Assay; Buprenorphine; Calibration; Chromatography, Liquid; Cyclopropanes; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Mass Spectrometry; Molecular Structure; Narcotic Antagonists; Oligopeptides; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Substance-Related Disorders; Tandem Mass Spectrometry | 2007 |
Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.
Topics: Adult; Analgesics, Opioid; Atazanavir Sulfate; Buprenorphine; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Ritonavir; Substance-Related Disorders | 2007 |
Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Chemical and Drug Induced Liver Injury; Cohort Studies; Dose-Response Relationship, Drug; Drug Interactions; HIV Infections; Humans; Naloxone; Oligopeptides; Opioid-Related Disorders; Pyridines | 2011 |